RNF186 controls glucose metabolism in metabolic dysfunction-associated fatty liver disease

Qizhang Du

doi:10.1186/s13578-025-01507-6

November 28, 2025Cell & BioscienceOpen Access

RNF186 controls glucose metabolism in metabolic dysfunction-associated fatty liver disease

View Full Paper

Ask AI

Bookmark

Share

Key Points

Glucose metabolism is influenced by RNF186 in metabolic dysfunction-associated fatty liver disease.
The mechanism involves the transcription and translocation of GLUT4 in skeletal muscle.
Transcriptional modulation by RNF186 suggests a direct therapeutic target for metabolic disorders.
The findings point to the potential therapeutic strategy targeting RNF186 in related metabolic conditions.

Ask about this paper

Answers are grounded in this paper and cite their sources.

Implication

Observational analysis reveals RNF186's impact on glucose metabolism in MAFLD, indicating potential for therapeutic strategies.

Abstract

RNF186 regulates glucose metabolism across multiple tissues in MAFLD, notably by playing a dual role in modulating the transcription and translocation of GLUT4 in skeletal muscle. These findings suggest that targeting the expression of RNF186 could be a potential therapeutic strategy for treating MAFLD and related metabolic disorders.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Qizhang Du (2025) studied this question.

synapsesocial.com/papers/692e3d846c9b3ab28c1874ba https://doi.org/10.1186/s13578-025-01507-6

View Full Paper

Ask AI

Bookmark

Share

RNF186 controls glucose metabolism in metabolic dysfunction-associated fatty liver disease

Key Points

Ask about this paper

Implication

Abstract

Discussion

Cite This Study

RNF186 controls glucose metabolism in metabolic dysfunction-associated fatty liver disease

Key Points

Ask about this paper

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading